AMCR vs BBNX · P/E 18, rev $23.51B vs rev $100.3M
Amcor PLC (AMCR) versus Beta Bionics, Inc. Common Stock (BBNX) — a side-by-side from cached financials, not a winner call.
Amcor PLC (AMCR) is a packaging & containers company listed on US.
Beta Bionics, Inc. Common Stock (BBNX) is a medical devices company listed on NASDAQ.
Latest reported AMCR revenue for 2026-06-30 was $23.51B. Net income was $1.11B. AMCR currently screens at market cap $22.52B and trailing P/E 17.6.
Latest reported BBNX revenue for 2025-12-31 was $100.3M. Net income was -$73.2M. Revenue was up 53.9% from 2024-12-31 to 2025-12-31. BBNX currently screens at market cap $640.8M.
AMCR currently screens at market cap $22.52B and trailing P/E 17.6. BBNX currently screens at market cap $640.8M.
Not investment advice. Open the AMCR and BBNX stock pages for the full models.
Not investment advice.